More than 120 genes have been reported to be associated with deafness, and deletion of the TBL1X gene may cause deafness in humans. In this study, we generated an induced pluripotent stem cell (iPSC) line from dermal fibroblasts of a 34-year-old deaf person with a novel variant c.342_343insGCGGCG in the TBL1X gene. The induced patient-specific iPSC line with a normal karyotype and expressed pluripotent markers, it also shows differentiation totipotency and tridermogenesis in vivo. It may be a good model for studying hearing loss in vitro and it will benefit to the development of new therapies for deafness.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.scr.2022.102761 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating gene expression datasets of hippocampus tissue to discover Alzheimer's disease-associated molecular markers.
J Alzheimers Dis
December 2024
Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.
Background: Alzheimer's disease (AD) is an advancing neurodegenerative disorder distinguished by the formation of amyloid plaques and neurofibrillary tangles in the human brain. Nevertheless, the lack of peripheral biomarkers that can detect the development of AD remains a significant limitation.
Objective: The main aim of this work was to discover the molecular markers associated with AD.
PPM1G-mediated TBL1X mRNA splicing promotes cell migration in hepatocellular carcinoma.
Cancer Sci
January 2025
MOE Key Laboratory of Tumor Molecular Biology and State Key Laboratory of Bioactive Molecules and Druggability Assessment, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China.
Article Synopsis
- The study explores how abnormal splicing of genes contributes to the progression of hepatocellular carcinoma (HCC) and identifies PPM1G as a key biomarker related to HCC metastasis.
- RNA sequencing revealed specific splice variants, particularly the TBL1X-S variant, regulated by PPM1G, which promotes metastasis in HCC.
- The research suggests that the interaction between PPM1G and TBL1X-S enhances processes like epithelial-mesenchymal transition (EMT), providing new insights into liver cancer metastasis mechanisms.
Design, Synthesis, and Biological Evaluation of Selective TBL1X Degraders.
ACS Med Chem Lett
October 2024
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States.
Transducin β-like protein 1 X-linked (TBL1X) is an essential scaffold protein involved in multiple signaling pathways, such as the Wnt/β-catenin pathway, where it protects β-catenin from ubiquitination and proteasomal degradation. Recent studies, however, suggest that TBL1X might modulate Wnt-regulated genes independently of β-catenin in diffuse large B-cell lymphoma (DLBCL). Here, we developed selective TBL1X degraders against DLBCL using the Proteolysis Targeting Chimeras (PROTACs) strategy as a proof-of-concept.
View Article and Find Full Text PDFMicroarray analysis points to LMNB1 and JUN as potential target genes for predicting metastasis promotion by etoposide in colorectal cancer.
Sci Rep
October 2024
Department of Colorectal Surgery, Tianjin Union Medical Center, Tianjin, People's Republic of China.
Article Synopsis
- * Researchers performed microarray analysis to identify differentially expressed genes (DEGs) between etoposide-treated and untreated colorectal cancer cells, revealing several key genes that interact with each other.
- * The study found that after etoposide treatment, processes like the cell cycle and metabolism were downregulated, while necroptosis and oncogene pathways were upregulated; two specific genes, LMNB1 and JUN, were identified as potential targets for understanding cancer metastasis.
Disturbed function of TBL1X has a differential effect on T3-regulated gene expression in two human liver cell models.
Eur Thyroid J
October 2024
Endocrine Laboratory, Department of Laboratory Medicine, University of Amsterdam, Amsterdam, the Netherlands.
Background: Mutations in TBL1X, part of the NCOR1/SMRT corepressor complex, were identified in patients with hereditary X-linked central congenital hypothyroidism and associated hearing loss. The role of TBL1X in thyroid hormone (TH) action, however, is incompletely understood. The aim of the present study was to investigate the role of TBL1X on T3-regulated gene expression in two human liver cell models.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!